State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, PR China; Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, PR China.
Bioorg Med Chem. 2013 Nov 1;21(21):6796-803. doi: 10.1016/j.bmc.2013.07.048. Epub 2013 Aug 6.
A water extract of the leaves of Suregada glomerulata (Euphorbiaceae) was found to inhibit rat small intestinal α-glucosidase. An examination of the extract afforded 20 iminosugars including one pyrrolidine and 19 piperidines. The structures of the 10 new compounds (11-20) were determined by NMR, and MS spectroscopic data analyses, and chemical correlations. The novelty of the identified compounds mainly stems from the loss of a hydroxy at C-4 and the presence of an 8-hydroxyoctyl side chain. Nine N-alkyl derivatives including N-methyl (1a, 8a, and 13a), N-butyl (1b, 2b, and 9b) and N,N-dimethyl (1c, 2c, and 9c) were synthesized. The compounds were tested for rat small intestinal α-glucosidase inhibitory activity. In total, 15 compounds, including compounds 11, 12, 15, and 19 and the three derivatives 8a, 9b, and 13a, showed inhibitory activity with IC50 values less than 40μM. In vivo results showed that total alkaloids of S. glomerulata (10mg/kg) and four major iminosugars 1, 2, 3, and 9 (10mg/kg) can lower the postprandial blood glucose level after sucrose and starch load in healthy male ICR mice.
从 Suregada glomerulata(大戟科)叶的水提取物中发现它可以抑制大鼠小肠α-葡萄糖苷酶。对提取物的检查得到了 20 种亚氨基糖,包括一个吡咯烷和 19 个哌啶。通过 NMR、MS 光谱数据分析和化学相关性确定了 10 种新化合物(11-20)的结构。鉴定出的化合物的新颖性主要源于 C-4 上失去一个羟基和存在 8-羟基辛基侧链。合成了 9 种 N-烷基衍生物,包括 N-甲基(1a、8a 和 13a)、N-丁基(1b、2b 和 9b)和 N,N-二甲基(1c、2c 和 9c)。对这些化合物进行了大鼠小肠α-葡萄糖苷酶抑制活性测试。共有 15 种化合物,包括化合物 11、12、15 和 19 以及三种衍生物 8a、9b 和 13a,其 IC50 值均小于 40μM,表现出抑制活性。体内结果表明,S. glomerulata 总生物碱(10mg/kg)和四种主要亚氨基糖 1、2、3 和 9(10mg/kg)可降低健康雄性 ICR 小鼠蔗糖和淀粉负荷后的餐后血糖水平。